SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
Introduction To Biomedical Engineering
Start Test
Study First
Subject
:
engineering
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. ?l/l0
strain - e
a 'biodegradable' product has the ability to break down
510(k)'s standard for clearance
degradation steps
2. Contains ribosomes - protein synthesis
rough ER
residual volume =
a completed PDP
central nervous system
3. Neared to the end of the limbs
distal
proximal
healing response
sacromere
4. Protocol submitted to IRB for approval
human subject research procedure 2
frontal plane
adduction
the protocol for human subject research
5. <25% results in heart failure
healing response
if the stroke volume is less than this
cell cycle (4)
non - therapeutic experiment example 2
6. Consists of all nervous tissue that is enclosed by bone (brain and spinal cord)
stress - s
What a PDP - sponsor and FDA agree on
class III examples
central nervous system
7. Cardiac output < demand
passive transport
heart failure
why 510(k)'s standard for clearance is lower
two ways larger molecules pass through cell membrane
8. Motion where angle of joint is decreased in the sagittal plane
non - therapeutic experiment example 2
flexion
lower ion concentration of Cl
synovial joints have
9. Growth phase 1
parietal pleura
class III
g1 - cell cycle
therapeutic experiment example 1
10. PMA - 510(k) notification - IDE - PDP
therapeutic experiment
routes for registerting a new medical device in the US (4)
why 510(k)'s standard for clearance is lower
anterior view
11. F/ A0
IDE
visceral pleura
stress - s
510(k) must prove this
12. Divides the body in left and right halves; aka median plane
device classification has
extension
510(k) must prove this
midsagittal plane
13. Closer to the head
superior
a completed PDP
therapeutic experiment example 1
conflict of interest - informed consent
14. lower ion concentration of Na
sacromere
Intracellular
PMA
anterior view
15. Number of subjects - safety assurances - privacy protection - informed consent documents
IRB review areas (4)
flexion
conflict of interest - informed consent
510(k)'s standard for clearance
16. The most important aspect governing the ethics of human experimentation
what microtubules contain
informed consent
cell cycle (4)
attaining informed consent (3)
17. The remainder of the pleura left in the cavity
parietal pleura
510(k)'s standard for clearance
milestones
larger molecules require
18. Total lung capacity - inspiratory capacity
functional residual capacity =
non - therapeutic experiment example 1
PMA
What a PDP - sponsor and FDA agree on
19. Basic functional unit of skeletal muscles
sacromere
microtubules
Lower ion concentration of K
510(k) must prove this
20. 2/3 diastolic pressure + 1/3 systolic pressure
510(k) must prove this
strain - e
polymers (5)
mean arterial pressure
21. Injury with tissue - bleeding and clotting (coagulation cascade) - acute inflammation - pink granulation tissues replaces matrix - tissue is remodeled back to original state
investigator
healing response
midsagittal plane
degradation steps
22. Moderate risk to the user; most require 510(k)
visceral pleura
cardiac output
class II
competence - informed consent
23. Rotational movement of forearm such that the palm is facing posterior when standing in anatomic position
s - cell cycle
pronation
the protocol for human subject research
non - therapeutic experiment
24. Revisions returned to investigator
human subject research procedure 3
residual volume =
synovial joints have
ER - golgi apparatus
25. As a osmotic barrier; phospholipid bilayer
routes for registerting a new medical device in the US (4)
class III
ER - golgi apparatus
plasma membrane acts
26. Closer to the feet
heart failure
inferior
FDA
during external respiration -
27. Rotational movement of forearm such that the palm is facing anterior when standing in anatomic position
supination
ceramics are (5)
510(k) must prove this
6 types of synovial joints
28. Mitosis
adduction
m - cell cycle
510(k)'s standard for clearance
class III
29. Total lung capacity - vital capacity
residual volume =
midsagittal plane
class III
What a PDP - sponsor and FDA agree on
30. V diastole - V systole
stroke volume
cardiac output
visceral pleura
larger molecules require
31. G1 - s - g2 - m
cell cycle (4)
heart rate given by (EKG)
synovial joints have
anterior view
32. Genotyping to determine risk factors for disease
non - therapeutic experiment
non - therapeutic experiment example 2
class III examples
cardiac output
33. Institutional review board - consider the ethical aspects - to evaluate - approve - and monitor proposals to perform human research
IRB
synovial joints have
Intracellular
stroke volume
34. Translations - appropriate language - obtained in writing - and informed that they may abstain or withdraw from the study at any time
passive transport
the protocol for human subject research
informed consent documents (4)
supination
35. Considered a successful PMA
FDA
a completed PDP
residual volume =
Hooke's law - s
36. Hollow - cylindrical structures that aid in cell division by transporting chromosomes
pulse pressure
microtubules
small molecules
non - therapeutic experiment
37. Food and drug administration - in charge of Regulating medical devices for their safety and effectiveness
FDA
class I
abduction
class III examples
38. Metals - ceramics - polymers - biologics
pulse pressure
abduction
human subject research procedure 4
classes of biomaterials (4)
39. __________ of PDP are reported to the FDA
milestones
biodegradable materials have
a 'biodegradable' product has the ability to break down
a completed PDP
40. One which has direct benefit to the patient
tumor suppressor gene
cell cycle (4)
therapeutic experiment
FDA
41. Because the devices may not state that they FDA- approved
Warning
: Invalid argument supplied for foreach() in
/var/www/html/basicversity.com/show_quiz.php
on line
183
42. Premarket approval - Are licenses to an individual company to market a specific device - require a lot of time and money to prove safety and effectiveness
IRB review areas (4)
PMA
IDE
ceramics are (5)
43. Trial of artificial kidneys
therapeutic experiment example 1
class II examples
therapeutic experiment example 2
Hooke's law - s
44. Front view (palms up)
anterior view
device classification has
tumor suppressor gene
class II examples
45. Intracellular
lower ion concentration of Cl
PMA
frontal plane
class III
46. DNA synthesis
stress - s
s - cell cycle
class II
g1 - cell cycle
47. Delivers and stores proteins and lipids
rough ER
ER - golgi apparatus
coronary arteries
What a PDP - sponsor and FDA agree on
48. Replacement heart valves - stents - breast implants
human subject research procedure 4
abduction
Hooke's law - s
class III examples
49. Back view (palms up)
posterior view
class II examples
medial
during external respiration -
50. Deliver oxygenated blood to cardiac tissue - derive oxygenated blood via Sinuses of Valsalva - fill with blood on diastole - heart muscle relaxes during diastole
g2 - cell cycle
during external respiration -
coronary arteries
how IDE's can be granted